agilon health, inc. Disposal Group, Including Discontinued Operation, Revenue
agilon health, inc. (AGL) reported Disposal Group, Including Discontinued Operation, Revenue of $525.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2023-03-01
- agilon health, inc. disposal group, including discontinued operation, revenue for the quarter ending 2022-12-31 was -$1.00K, a 100.06% decline year-over-year.
- agilon health, inc. disposal group, including discontinued operation, revenue for the quarter ending 2022-09-30 was $5.00K, a 99.61% decline year-over-year.
- agilon health, inc. disposal group, including discontinued operation, revenue for the quarter ending 2022-06-30 was $177.00K.
- agilon health, inc. disposal group, including discontinued operation, revenue for the quarter ending 2022-03-31 was $344.00K, a 91.11% decline year-over-year.
- agilon health, inc. disposal group, including discontinued operation, revenue for fiscal 2022 was $525.00K, a 91.85% decline from fiscal 2021.
- agilon health, inc. disposal group, including discontinued operation, revenue for fiscal 2021 was $6.44M, a 95.85% decline from fiscal 2020.
- agilon health, inc. disposal group, including discontinued operation, revenue for fiscal 2020 was $155.30M, a 26.02% decline from fiscal 2019.
- agilon health, inc. disposal group, including discontinued operation, revenue for fiscal 2019 was $209.93M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 3 month as first filed | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.00K derived: sum of 2 quarters · filed 2023-03-01 | $181.00K derived: sum of 3 quarters · filed 2023-03-01 | $525.00K 10-K · filed 2023-03-01 | |
| 2022-09-30 | $5.00K 10-Q · filed 2022-11-03 | $182.00K derived: sum of 2 quarters · filed 2022-11-03 | $526.00K 10-Q · filed 2022-11-03 | $2.34M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-06-30 | $177.00K 10-Q · filed 2022-08-04 | $521.00K 10-Q · filed 2022-08-04 | $2.33M derived: sum of 3 quarters · filed 2023-03-01 | $3.63M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-03-31 | $344.00K 10-Q · filed 2022-05-05 | $2.15M derived: sum of 2 quarters · filed 2023-03-01 | $3.45M derived: sum of 3 quarters · filed 2023-03-01 | $2.92M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.11M derived: sum of 2 quarters · filed 2023-03-01 | $2.57M derived: sum of 3 quarters · filed 2023-03-01 | $6.44M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $1.30M 10-Q · filed 2022-11-03 | $763.00K derived: sum of 2 quarters · filed 2022-11-03 | $4.63M 10-Q · filed 2022-11-03 | $17.13M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$534.00K 10-Q · filed 2022-08-04 | $534.00K 10-Q · filed 2021-08-04 | $3.34M 10-Q · filed 2022-08-04 | $15.84M derived: sum of 3 quarters · filed 2023-03-01 | $56.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.87M 10-Q · filed 2022-05-05 | $16.37M derived: sum of 2 quarters · filed 2023-03-01 | $57.11M derived: sum of 3 quarters · filed 2023-03-01 | $108.93M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $53.24M derived: sum of 2 quarters · filed 2023-03-01 | $105.06M derived: sum of 3 quarters · filed 2023-03-01 | $155.30M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $40.74M 10-Q · filed 2021-10-28 | $92.56M derived: sum of 2 quarters · filed 2021-10-28 | $142.80M 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $51.81M 10-Q · filed 2021-08-04 | $102.05M 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | $50.24M 10-Q · filed 2021-05-26 | ||||
| 2019-12-31 | $209.93M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |